Bevan, C*
Imperial College London
H-index: 39
Europe-United Kingdom
Top articles of Bevan, C*
The antiviral potential of the antiandrogen enzalutamide and the viral‐androgen signaling interplay in seasonal coronaviruses
2023
Correction: The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer
British journal of cancer
2024/2/14
Targeting androgen receptor coregulators to enhance enzalutamide sensitivity in prostate cancer
Cancer Research
2023/4/4
Apoptosis-modulatory miR-361-3p as a novel treatment target in endocrine-responsive and endocrine-resistant breast cancer
Journal of Endocrinology
2023/3/1
Selective non-lipogenic ABCA1 inducer, CL2-57, affects cholesterol efflux pathways and adrenocortical cancer cell migration in 2D and 3D spheroid models
Endocrine Abstracts
2023/10/31
Communication between peri-prostatic adipocytes and epithelial cells drives prostate cancer aggressivity in obese men
Endocrine Abstracts
2023/10/31
PLK1 Regulates MicroRNA Biogenesis through Drosha Phosphorylation
International Journal of Molecular Sciences
2023/9/19
Handheld ISFET Lab-on-Chip detection of TMPRSS2-ERG and AR mRNA for prostate cancer prognostics
IEEE sensors letters
2023/7/17
The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer
British Journal of Cancer
2023/6/29
AMPK activation protects against prostate cancer by inducing a catabolic cellular state
Cell reports
2023/4/25
Liver microenvironment response to prostate cancer metastasis and hormonal therapy
2022/12/15
Detection of YAP1 and AR-V7 mRNA for prostate cancer prognosis using an ISFET lab-on-chip platform
ACS sensors
2022/11/11
Androgen receptor splice-variants in granulosa-lutein cells of women with polycystic ovary syndrome (PCOS)
Endocrine Abstracts
2022/10/27
Post-Transcriptional regulation of wild-type and variant androgen receptors during prostate cancer progression
Endocrine Abstracts
2022/10/27
Epigenetic Coregulation of Androgen Receptor Signaling
2022/9/16
Nuclear Receptors in Human Health and Disease
2022/9/15
Cellular specificity of androgen receptor, coregulators, and pioneer factors in prostate cancer
2022/9/1
Transcription associated cyclin-dependent kinases as therapeutic targets for prostate cancer
2022/6/10
A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer
Molecular Cancer
2022/3/22
MicroRNAs as biomarkers for prostate cancer prognosis: a systematic review and a systematic reanalysis of public data
2022/2/1
Co-Authors
